Related Experiment Video
Updated: Jun 25, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
Published on: March 6, 2018
Dydrogesterone use during pregnancy: overview of birth defects reported since 1977
1Birth Registry Mainz Model, Universitätskinderklinik, Johannes Gutenberg-University Mainz, Mainz, Germany. queisser@kinder.klinik.uni-mainz.de
Abstract:
Between 1977 and 2005, 28 cases of potential links between maternal dydrogesterone use during pregnancy and congenital birth defects were reported. The types of defects were very diverse, with no evidence of a pattern of abnormalities. The data do not provide evidence for congenital malformations associated with dydrogesterone use.
Related Concept Videos
Teratogenicity
Intrauterine Drug Delivery Systems
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Regulation
Birth Control Methods
Drug Toxicity: Risk factors